[HTML][HTML] CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-γ+ Th1 Cells or Foxp3+ Regulatory T Cells in the Lung
Purpose CpG oligodeoxynucleotide (CpG-ODN), a TLR9 agonist, activates innate immunity
and induces Th1 response. Although the immune modulatory effect of CpG-ODN has been …
and induces Th1 response. Although the immune modulatory effect of CpG-ODN has been …
Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA …
Schistosomiasis is a major public health problem that affects mainly developing countries.
There are 200 million people worldwide infected with schistosomes resulting in more than …
There are 200 million people worldwide infected with schistosomes resulting in more than …
[HTML][HTML] Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells
C Grandjenette, A Kennel, GC Faure, MC Bene… - …, 2007 - haematologica.org
This study reports that B-chronic lymphocytic leukemia (B-CLL) cells display the same
pattern of toll-like receptors (TLRs) proteins expression as normal B-cells, yet with …
pattern of toll-like receptors (TLRs) proteins expression as normal B-cells, yet with …
Altered maturation of circulating dendritic cells in primary progressive MS patients
C López, M Comabella, H Al-Zayat, M Tintoré… - Journal of …, 2006 - Elsevier
We investigated the phenotype and frequency of circulating myeloid dendritic cells (MDC)
and plasmacytoid DC (PDC) in 86 multiple sclerosis (MS) patients and 33 healthy controls …
and plasmacytoid DC (PDC) in 86 multiple sclerosis (MS) patients and 33 healthy controls …
[HTML][HTML] Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy
Objective (s): Program death 1 (PD-1)/program death-ligand 1 (PD-L1) pathways, as the
main inhibitory checkpoints, induce immunosuppression in the tumor microenvironment …
main inhibitory checkpoints, induce immunosuppression in the tumor microenvironment …
CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague
K Amemiya, JL Meyers, TE Rogers, RL Fast… - Vaccine, 2009 - Elsevier
The current US Department of Defense candidate plague vaccine is a fusion between two
Yersinia pestis proteins: the F1 capsular protein, and the low calcium response (Lcr) V …
Yersinia pestis proteins: the F1 capsular protein, and the low calcium response (Lcr) V …
Progress in control measures for chicken coccidiosis
A Kitandu, R Juranova - Acta Veterinaria Brno, 2006 - actavet.vfu.cz
For many years, prophylactic use of anticoccidial drugs has been the primary means of
controlling chicken coccidiosis in broiler industry and has played a major role in the growth …
controlling chicken coccidiosis in broiler industry and has played a major role in the growth …
Development of CpG ODN based vaccine adjuvant formulations
Abstract Development of effective vaccine mediated immune responses relies on the use of
vaccine adjuvants capable of enhancing and directing the adaptive immune response to the …
vaccine adjuvants capable of enhancing and directing the adaptive immune response to the …
[PDF][PDF] Genetically modified live attenuated parasites as vaccines for leishmaniasis
A Selvapandiyan, R Duncan, A Debrabant… - Indian journal of …, 2006 - researchgate.net
Leishmaniasis causes significant morbidity and mortality worldwide and is an important
public health problem. Even though it is endemic in developing countries in tropical regions …
public health problem. Even though it is endemic in developing countries in tropical regions …
The Effect of TLR9 Agonist CpG Oligodeoxynucleotides on the Intestinal Immune Response of Cobia (Rachycentron canadum)
O Byadgi, D Puteri, JW Lee, TC Chang… - Journal of …, 2014 - Wiley Online Library
Cytosine‐guanine oligodeoxynucleotide (CpG ODN) motifs of bacterial DNA are recognized
through toll‐like receptor 9 (TLR9) and are potent activators of innate immunity. However …
through toll‐like receptor 9 (TLR9) and are potent activators of innate immunity. However …